Program to enhance heart health in patients getting stem cell transplants
Official title: Cardio-Oncology Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
Run by University of Michigan Rogel Cancer Center · NCT05945121 · Data updated 2026-11-12
This study tests a heart health program for patients with cardiovascular risks who are getting stem cell transplants to see if it helps them get fitter and avoid heart problems.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10 (estimated) |
| Sponsor | University of Michigan Rogel Cancer Center Academic / other |
| Locations | 1 site (Ann Arbor, Michigan) |
| Status | Recruiting |
| Started | August 25, 2023 |
| Main results expected | August 2027 |
| Study ends | August 2027 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT05945121 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are referred for hematopoietic stem cell transplantation and have at least one cardiovascular risk factor.
✕Probably not a fit
Patients with severe cardiovascular conditions or those unable to ambulate unassisted may not benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates a Cardio-Oncology Prehabilitation program aimed at improving cardiorespiratory fitness and reducing cardiovascular complications in high-risk patients undergoing hematopoietic stem cell transplantation. It focuses on patients with existing cardiovascular risk factors and assesses the feasibility and preliminary effectiveness of the intervention. Participants will engage in a structured program designed to enhance their cardiovascular health before the transplant procedure.
Why it matters
Potential benefit: If successful, this program could significantly improve heart health and reduce complications for patients undergoing stem cell transplants.
How similar studies have gone: Other studies have shown promising results with prehabilitation programs in similar patient populations, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult 18 years or older * Referred for HSCT evaluation * Presence of least one CV risk factor at enrollment (hypertension, hyperlipidemia, atrial fibrillation, obesity, heart failure, history of coronary artery disease, diabetes) * Able to ambulate unassisted * Ability to understand and the willingness to sign a written informed consent * Ability to use Polar Flow heart rate application Exclusion Criteria: * Severe anemia (hemoglobin \<7 gm/dl) * Untreated high-risk coronary artery disease (left main, triple vessel disease) * Severe aortic stenosis * Recent fracture as assessed via self-report * Gross balance deficits * Severe pain with basic movement * Unable to ambulate unassisted or exercise * NYHA class IV heart failure * Adults unable to give consent, pregnant women, and prisoners are excluded from this study.
Where it's running
-
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, United States Recruiting
Study contacts
- Principal investigator: Salim Hayek — University of Michigan Rogel Cancer Center
- Study coordinator: Cancer AnswerLine
- Email: CancerAnswerLine@med.umich.edu
- Phone: 1-800-865-1125
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early Cognitive Behavioral Therapy for Insomnia Before Stem Cell Transplant
This trial tests whether starting six telehealth CBT-I sessions before hematopoietic stem cell transplant can help adults with insomnia feel better and have less fatigue.
-
Coping skills training for patients after stem cell transplant
This study is testing a new coping skills program to see if it helps people who have had a stem cell transplant manage pain, fatigue, and stress better than usual care.
-
Preventing GvHD in patients with blood cancers undergoing stem cell transplants
This study is testing a new treatment called TRX-103 to see if it can help prevent graft-versus-host disease in people with blood cancers who are getting stem cell transplants from mismatched donors.
-
Positive psychology support for survivors of stem cell transplants
This study is testing a new program that helps people who have had stem cell transplants feel happier and less anxious by encouraging them to do enjoyable activities.
-
T Cell Therapy for Cytomegalovirus Infections
This study is testing whether using special immune cells from donors can help patients who had a stem cell transplant fight off cytomegalovirus infections.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.